King Faisal Specialist Hospital, Riyadh – United Arab Emirates
About Dr. Abdulrahman Alghabban
Dr. Abdulrahman Alghabban is a Consultant in General Oncology specialising in the medical management of solid tumours, thromboembolic complications in cancer, and supportive oncology care for international patients seeking expert general oncology specialist care in Riyadh, Saudi Arabia. He contributes to multidisciplinary tumour boards and oncology research at a leading tertiary cancer centre in the region.
- Consultant in General Oncology treating the full spectrum of solid tumour malignancies
- Co-author of peer-reviewed research on venous thromboembolism in cancer patients
- Experienced in managing international oncology patients from Gulf, Africa, and South Asia
- Trained as Chief Resident at one of the Middle East's top tertiary centres
- Expert in evidence-based chemotherapy, targeted therapy, and immunotherapy protocols
Qualifications & Credentials
Medical Degrees
- MBBS — Bachelor of Medicine and Bachelor of Surgery
- Internal Medicine Residency
Fellowships & Special Training
- Fellowship — Medical Oncology
- Chief Resident Training — King Faisal Specialist Hospital & Research Centre
Certifications & Accreditations
- Saudi Commission for Health Specialties (SCFHS) — Consultant
Areas of Expertise
Major Conditions Treated
- Breast Cancer
- Colorectal Cancer
- Lung Cancer
- Gastric and Oesophageal Cancer
- Pancreatic Cancer
- Hepatocellular Carcinoma
- Prostate Cancer
- Head and Neck Cancers
- Genitourinary Malignancies
- Cancer-Associated Venous Thromboembolism
- Tumours of Unknown Primary
Sub-specialties
- Solid Tumour Medical Oncology: Evidence-based chemotherapy, targeted therapy, and immunotherapy for solid tumours — a trusted general oncology specialist in Riyadh for international patients seeking comprehensive cancer care.
- Onco-Thrombosis Management: Prevention and management of venous thromboembolism (VTE) in cancer patients, including primary prophylaxis and treatment with anticoagulation.
- Multidisciplinary Tumour Board Care: Participates in tumour board reviews to coordinate surgical, radiation, and medical oncology for each patient.
Advanced Procedures & Treatments
- Chemotherapy Administration (IV and Oral Regimens)
- Targeted Therapy (EGFR, HER2, VEGF inhibitors)
- Immunotherapy / Checkpoint Inhibitors (PD-1, PD-L1)
- Hormonal Therapy (Breast, Prostate Cancer)
- VTE Prophylaxis and Management
- Tumour Marker Monitoring
- Palliative and Supportive Care Planning
Professional Experience
Current Affiliation
- King Faisal Specialist Hospital & Research Centre (KFSHRC), Riyadh — Consultant, General Oncology, Oncology Centre (Present)
Past Affiliations
- King Faisal Specialist Hospital & Research Centre, Riyadh — Chief Resident (Past)
Academic & Research Roles
- Contributor — KFSHRC Oncology Centre Multidisciplinary Tumour Board
Key Achievements
- Co-author of published research on thromboembolic burden in solid tumour patients
- Trained as Chief Resident at KFSHRC — one of the Middle East's leading tertiary referral centres
- Experienced in treating international oncology patients from GCC, Africa, and South Asia
Awards & Recognitions
National & International Awards
- Information not publicly available.
Professional Memberships
- Saudi Oncology Society
- European Society for Medical Oncology (ESMO)
Research & Publications
Published Papers (Selected)
- Bazarbashi S, Alkhaldi T, Aseafan M, ..., Alghabban A, et al. "Thromboembolic Events Burden in Patients With Solid Tumors and Their Predisposing Factors." Cureus. 2022. Accepted 2022 Mar 29. PMC8967125.
Ongoing Research & Clinical Interests
- Venous thromboembolism in solid tumour patients
- Chemotherapy outcomes in advanced solid tumours
- Targeted therapy and immunotherapy integration in Middle Eastern populations
Estimated Treatment Costs
| Procedure / Consultation | Estimated Cost (INR) | Estimated Cost (USD) |
|---|---|---|
| Medical Oncology Consultation | ₹1,500 – ₹4,000 | $18 – $48 |
| Chemotherapy (per cycle, regimen-dependent) | ₹20,000 – ₹1,50,000 | $240 – $1,800 |
| Targeted Therapy (per month, drug-dependent) | ₹50,000 – ₹3,00,000 | $600 – $3,600 |
| Immunotherapy (per cycle) | ₹80,000 – ₹2,50,000 | $960 – $3,000 |
| Tumour Marker / Biomarker Panel | ₹5,000 – ₹50,000 | $60 – $600 |
*Indicative estimates only. Actual costs subject to hospital pricing, case complexity, and insurance. Contact Cancer Rounds for a personalised quote.
Frequently Asked Questions
1. What advanced technologies does Dr. Abdulrahman Alghabban use in General Oncology treatment?
Dr. Abdulrahman Alghabban uses evidence-based chemotherapy, targeted therapies (EGFR, HER2, VEGF inhibitors), immune checkpoint inhibitors (PD-1, PD-L1), hormonal therapies, and biomarker-guided precision oncology protocols. Virtual consultations are available for international patients. Contact Cancer Rounds for a detailed technology overview.
2. What conditions does Dr. Abdulrahman Alghabban specialize in treating?
Dr. Abdulrahman Alghabban specialises in a broad spectrum of solid tumour malignancies including breast, colorectal, lung, gastric, pancreatic, hepatocellular, prostate, and head and neck cancers. He also manages cancer-associated thromboembolic complications and tumours of unknown primary — as a leading general oncology specialist in Riyadh, Saudi Arabia.
3. How do I book an appointment with Dr. Abdulrahman Alghabban?
Appointments with Dr. Abdulrahman Alghabban can be booked directly through the Cancer Rounds website or by contacting their international patient department for priority scheduling.
4. Can international patients receive treatment from Dr. Abdulrahman Alghabban?
Yes. Cancer Rounds provides full assistance for international patients seeking treatment from Dr. Abdulrahman Alghabban, including medical visa invitation letters, airport transfers, and local accommodation coordination.
5. What support is available for international patients?
International patients benefit from a dedicated concierge service provided by Cancer Rounds, including language interpretation, financial counselling, and pre-travel virtual consultations to review medical records before arrival.
6. Does Dr. Abdulrahman Alghabban offer second opinions for General Oncology cases?
Yes. Second opinion consultations for General Oncology can be arranged via Cancer Rounds for patients who wish to review their diagnosis or treatment plan with an expert medical oncologist in Riyadh, Saudi Arabia.
